Organogenesis Holdings (ORGO) Current Taxes (2015 - 2018)
Organogenesis Holdings' (ORGO) quarterly Current Taxes came in at $700000.0 in Q3 2018, up 47.37% quarter-over-quarter from $475000.0 in Q2 2018.
Organogenesis Holdings (ORGO) Current Taxes (2015 - 2018) Analysis & Trends
Organogenesis Holdings' Current Taxes history runs 4 years deep, the most recent figure standing at $700000.0 for Q3 2018.
- On a quarterly basis, Current Taxes changed N/A year-over-year to $700000.0 in Q3 2018; TTM through Sep 2018 was $700000.0, a N/A change from a year earlier, with the FY2017 full-year figure at $100000.0, changed N/A from the prior year.
- Current Taxes advanced to $700000.0 in Q3 2018 per ORGO's latest filing, from $475000.0 in the prior quarter.
- Across five years, Current Taxes topped out at $700000.0 in Q3 2018 and bottomed at $100000.0 in Q4 2017.
- The 4-year median for Current Taxes is $300000.0 (2016), against an average of $341666.7.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 355.15 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 211.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 624.14 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 640.78 Mn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Organogenesis Holdings | 310.55 Mn | 218.45 Mn | 11.46 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 700,000.00 |
| Jun 30, 2018 | 475,000.00 |
| Mar 31, 2018 | 300,000.00 |
| Dec 31, 2017 | 100,000.00 |
| Sep 30, 2016 | 300,000.00 |
| Dec 31, 2015 | 175,000.00 |